Clinical Trials Directory

Trials / Completed

CompletedNCT03706781

A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer

A Phase I Study of a Novel Mouthwash Formulation (Cetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15% + Mucus - Adhesive Polymer) Administered Twice a Day for 7 Days to Healthy Subjects in Comparison With Marketed Tantum Verde Bocca Mouthwash Solution

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to evaluate the local tolerability and the systemic availability of benzydamine, if any, after single and multiple dose treatment with the test formulation containing cetylpyridinium chloride 0.05% + benzydamine hydrochloride 0.15% + mucoadhesive polymer and with the reference formulation Tantum Verde Bocca containing cetylpyridinium chloride 0.05% + benzydamine hydrochloride 0.15% to healthy subjects , under fasting conditions, in two consecutive study periods.

Conditions

Interventions

TypeNameDescription
DRUGCetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15% + mucus adhesive polymerTest product will be applied twice a day (b.i.d) every 12 h once in the morning and once in the evening for 6 consecutive days (from Day 1 to Day 6) and once in the morning on Day 7 for a total of 13 dose
DRUGCetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15%Reference Product will be applied twice a day (b.i.d) every 12 h once in the morning and once in the evening for 6 consecutive days (from Day 1 to Day 6) and once in the morning on Day 7 for a total of 13 dose

Timeline

Start date
2017-11-14
Primary completion
2017-12-18
Completion
2018-03-30
First posted
2018-10-16
Last updated
2020-08-05

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03706781. Inclusion in this directory is not an endorsement.